Global Cardiac Biomarkers Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023

  • ID: 3765888
  • Report
  • Region: Global
  • 140 pages
  • Occams Business Research and Consulting
1 of 5

FEATURED COMPANIES

  • Abbott Diagnostics
  • Beckman Coulter
  • Bg Medicine Inc.
  • Merck & Co, Inc.
  • Randox Laboratory
  • Roche Holding Ag
  • MORE
The global cardiac biomarker market is expected to generate the revenue of $2,225.9 million by 2022, registering a CAGR of 19.5% from 2016 to 2022. The prevention of cardiac diseases, by active monitoring the heart conditions by using cardiac biomarker testing is the newest approach for obtaining fastest output of immediate diagnosing and treatment of cardiac deceases. Cardiac biomarkers are made by protein-based traceable substances used as an indicator to assess biological state and for diagnosing the proactive purposes associated with heart. Cardiac biomarkers are also used as risk calculation for various cardiovascular diseases (CVDs), including myocardial congestive heart failure, infraction, acute coronary syndrome (ACS) among others deceases.

The promising features of markers such as high accuracy, rapid outcomes and affordable pricing of cardiac point of care (POC) testing is supporting the market of cardiac biomarker for the growth, worldwide. To keep the momentum stable of cardiac marker tests, the key manufacturers offers customized solutions. However, limited availability in some cases and side effects such as skeletal muscle injury is hindering the growth of cardiac biomarkers market. However, concerns related to single measurement cardiac biomarkers, high pricing of the devices and certain government regulations is expected to restrain the market to grow.

The global cardiac biomarkers market is basically segmented on the basis of type, application, location of testing and geography. Based on type of cardiac biomarkers, the market is divided into Creatine Kinase (CK-MB), Troponins T and I, myoglobin, BNPs, IMA and others. Troponins I and T are the largest revenue-generating segment in the overall cardiac biomarkers market because of its prodigious specialty and its ability to detect accurately the cardiac events of Acute Coronary Syndrome (ACS).

Based on application segment, the market is subdivided into myocardial infarction, congestive heart failure, atherosclerosis acute coronary syndrome, and others. Myocardial infarction (MI) accounts the highest market share in the global cardiac biomarker market and it is followed by acute coronary syndrome (ACS) because of its highest prevalence rate in all the cardiovascular diseases (CVDs). The location of testing segment is classified under point of care testing and laboratory testing. Doctors and clinicians majorly use point of care cardiac testing for quick monitoring and diagnosing patients with having chest pain in an emergency care unit, therefore, it accounts for the fastest growing CAGR in the forecasted period. However, laboratory testing segment is generating larger revenue in comparison to point of care testing now-a-days.

On the basis of geography, the global cardiac biomarker market is divided into North America, Europe, Asia-Pacific and LAMEA. Out of which North America is leading the global market, owing to the high demand for cardiac testing, high CVD prevalence rates and growing awareness towards cardiac diagnostics solutions. Asia-Pacific is emerging region with fastest growing CAGR due to the modernization in the countries, increasing disposable incomes and increasing affordability for the advanced cardiac treatments.

Key companies working in this market are Roche Diagnostics, Siemens Healthcare, Becton, Alere Inc., BioMerieux, Abbott Laboratories, Bio-Rad Laboratories, Dickinson and Company, Randox laboratories, Beckman Coulter and Thermo Fisher Scientific. Product launch and technological advancements are the few strategies adopted by the key players of global market. Biomarkers production companies are currently focusing on innovative technologies such as automated, multi-assay using combinations of cardiac biomarkers and point-of-care cardiac biomarker devices.

Note:
Please allow up to 72 hours for delivery.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Diagnostics
  • Beckman Coulter
  • Bg Medicine Inc.
  • Merck & Co, Inc.
  • Randox Laboratory
  • Roche Holding Ag
  • MORE
1. Introduction
1.1. Executive Summary
1.2. Estimation Methodology

2. Market Overview
2.1. Market Definition And Scope
2.2. Key Findings
2.3. Parametric Analysis
2.4. Key Market Insights
2.4.1. Top 3 Emerging Countries
2.4.2. Top 3 Revenue Generating Segments
2.4.3. Top Growing Markets And Emerging Trends
2.4.4. Top 3 Geography
2.5. Competitive Landscape
2.5.1. Market Share Analysis
2.5.2. Top Winning Strategies
2.5.3. Case Studies: Top Competitive Moves
2.6. Porter’S Five Force Model
2.6.1. Threat of New Entrants
2.6.2. Threat of Substitute Products Or Services
2.6.3. Bargaining Power of Buyer
2.6.4. Bargaining Power of Supplier
2.6.5. Intensity of Competitive Rivalry
2.7. Key Buying Criteria
2.8. Strategic Recommendation
2.9. Strategic Conclusions

3. Market Determinants
3.1. Market Drivers
3.1.1. Rising Prevalence of Cardiovascular Diseases
3.1.2. Cost Effective Device
3.1.3. Non-Invasive Method
3.1.4. Accuracy in Prediction
3.1.5. Helpful in Clinical Trials
3.1.6. Multi-Application
3.1.7. Technological Advancements Using Cardiac Biomarkers Combinations
3.1.8. Increasing Point of Care (Poc) Application
3.2. Market Restraints
3.2.1. Government Regulations
3.2.2. Confirmation in Result
3.2.3. Complex Production Process
3.3. Market Opportunities
3.3.1. Demand of Personalized Medicine
3.3.2. Point of Care (Poc) Testing Using Cardiac Biomarkers
3.3.3. Future Developments in Novel Cardiac Biomarkers
3.4. Market Challenges
3.4.1. Approval Clinical Validity And Utility of Biomarkers-Based Tests
3.5. Parent Market
3.6. Competitors Market
3.7. Alternative Market

4. Market Segmentation
4.1. By Location of Testing
4.1.1. Point of Care
4.1.2. Laboratory Testing
4.2. By Type
4.2.1. Creatine Kinase (Ck-Mb)
4.2.2. Troponins(T,I)
4.2.3. Myoglobin
4.2.4. Natriuretic Peptides (Bnp And Nt-Probnp)
4.2.5. Ischemia Modified Albumin
4.2.6. Others
4.3. By Application
4.3.1. Myocardial Infarction
4.3.2. Congestive Heart Failure
4.3.3. Acute Coronary Syndrome
4.3.4. Atherosclerosis
4.3.5. Others

5. Geographical Analysis
5.1. North America Cardiac Biomarkers Market 2014-2022 ($ Million)
5.1.1. United States (U.S.) Cardiac Biomarkers Market 2014-2022 ($ Million)
5.1.2. Canada Cardiac Biomarkers Market 2014-2022 ($ Million)
5.2. Europe Cardiac Biomarkers Market 2014-2022 ($ Million)
5.2.1. United Kingdom (Uk) Cardiac Biomarkers Market 2014-2022 ($ Million)
5.2.2. France Cardiac Biomarkers Market 2014-2022 ($ Million)
5.2.3. Germany Cardiac Biomarkers Market 2014-2022 ($ Million)
5.2.4. Spain Cardiac Biomarkers Market 2014-2022 ($ Million)
5.2.5. Italy Cardiac Biomarkers Market 2014-2022 ($ Million)
5.2.6. Roe Cardiac Biomarkers Market 2014-2022 ($ Million)
5.3. Asia Pacific Cardiac Biomarkers Market 2014-2022 ($ Million)
5.3.1. India Cardiac Biomarkers Market 2014-2022 ($ Million)
5.3.2. China Cardiac Biomarkers Market 2014-2022 ($ Million)
5.3.3. Japan Cardiac Biomarkers Market 2014-2022 ($ Million)
5.3.4. Korea Cardiac Biomarkers Market 2014-2022 ($ Million)
5.3.5. Australia Cardiac Biomarkers Market 2014-2022 ($ Million)
5.3.6. Roapac Cardiac Biomarkers Market 2014-2022 ($ Million)
5.4. Rest of the World Cardiac Biomarkers Market 2014-2022 ($ Million)
5.4.1. Latin America Cardiac Biomarkers Market 2014-2022 ($ Million)
5.4.2. Mena Cardiac Biomarkers Market 2014-2022 ($ Million)
5.4.3. Africa Cardiac Biomarkers Market 2014-2022 ($ Million)

6. Company Profile
6.1. Abbott Diagnostics
6.2. Alere Inc.
6.3. Beckman Coulter
6.4. Becton, Dickinson And Co.
6.5. Bg Medicine Inc.
6.6. Biomerieux
6.7. Ekf Diagnostics Holdings, Inc.
6.8. Merck & Co, Inc.
6.9. Radiometer Medical
6.10. Randox Laboratory
6.11. Response Biomedical
6.12. Roche Holding Ag
6.13. Siemens Healthcare
6.14. Singulex
6.15. Thermo Fisher Scientific

List of Tables
1. Global Cardiac Biomarkers Market By Location of Testing 2014-2022 ($ Million)
2. Global Cardiac Biomarkers Market By Point of Care 2014-2022 ($ Million)
3. Global Cardiac Biomarkers Market By Laboratory Testing 2014-2022 ($ Million)
4. Global Cardiac Biomarkers Market By Type 2014-2022 ($ Million)
5. Global Cardiac Biomarkers Market By Creatine Kinase (Ck-Mb) 2014-2022 ($ Million)
6. Global Cardiac Biomarkers Market By Troponins(T,I) 2014-2022 ($ Million)
7. Global Cardiac Biomarkers Market By Myoglobin 2014-2022 ($ Million)
8. Global Cardiac Biomarkers Market By Natriuretic Peptides (Bnp And Nt-Probnp) 2014-2022 ($ Million)
9. Global Cardiac Biomarkers Market By Ischemia Modified Albumin 2014-2022 ($ Million)
10. Global Cardiac Biomarkers Market By Others 2014-2022 ($ Million)
11. Global Cardiac Biomarkers Market By Application 2014-2022 ($ Million)
12. Global Cardiac Biomarkers Market By Myocardial Infarction 2014-2022 ($ Million)
13. Global Cardiac Biomarkers Market By Congestive Heart Failure 2014-2022 ($ Million)
14. Global Cardiac Biomarkers Market By Acute Coronary Syndrome 2014-2022 ($ Million)
15. Global Cardiac Biomarkers Market By Atherosclerosis 2014-2022 ($ Million)
16. Global Cardiac Biomarkers Market By Others 2014-2022 ($ Million)
17. North America Cardiac Biomarkers Market 2014-2022 ($ Million)
18. Europe Cardiac Biomarkers Market 2014-2022 ($ Million)
19. Asia Pacific Cardiac Biomarkers Market 2014-2022 ($ Million)
20. Rest of the World Cardiac Biomarkers Market 2014-2022 ($ Million)

List of Figures
1. Global Cardiac Biomarkers Market By Point of Care 2014-2022 ($ Million)
2. Global Cardiac Biomarkers Market By Laboratory Testing 2014-2022 ($ Million)
3. Global Cardiac Biomarkers Market By Creatine Kinase (Ck-Mb) 2014-2022 ($ Million)
4. Global Cardiac Biomarkers Market By Troponins(T,I) 2014-2022 ($ Million)
5. Global Cardiac Biomarkers Market By Myoglobin 2014-2022 ($ Million)
6. Global Cardiac Biomarkers Market By Natriuretic Peptides (Bnp And Nt-Probnp) 2014-2022 ($ Million)
7. Global Cardiac Biomarkers Market By Ischemia Modified Albumin 2014-2022 ($ Million)
8. Global Cardiac Biomarkers Market By Others 2014-2022 ($ Million)
9. Global Cardiac Biomarkers Market By Myocardial Infarction 2014-2022 ($ Million)
10. Global Cardiac Biomarkers Market By Congestive Heart Failure 2014-2022 ($ Million)
11. Global Cardiac Biomarkers Market By Acute Coronary Syndrome 2014-2022 ($ Million)
12. Global Cardiac Biomarkers Market By Atherosclerosis 2014-2022, ($ Million)
13. Global Cardiac Biomarkers Market By Others 2014-2022 ($ Million)
14. North America Cardiac Biomarkers Market 2014-2022 ($ Million)
15. United States (U.S.) Cardiac Biomarkers Market 2014-2022 ($ Million)
16. Canada Cardiac Biomarkers Market 2014-2022 ($ Million)
17. Europe Cardiac Biomarkers Market 2014-2022 ($ Million)
18. United Kingdom (Uk) Cardiac Biomarkers Market 2014-2022 ($ Million)
19. France Cardiac Biomarkers Market 2014-2022 ($ Million)
20. Germany Cardiac Biomarkers Market 2014-2022 ($ Million)
21. Spain Cardiac Biomarkers Market 2014-2022 ($ Million)
22. Italy Cardiac Biomarkers Market 2014-2022 ($ Million)
23. Roe Cardiac Biomarkers Market 2014-2022 ($ Million)
24. Asia Pacific Cardiac Biomarkers Market 2014-2022 ($ Million)
25. India Cardiac Biomarkers Market 2014-2022 ($ Million)
26. China Cardiac Biomarkers Market 2014-2022 ($ Million)
27. Japan Cardiac Biomarkers Market 2014-2022 ($ Million)
28. Korea Cardiac Biomarkers Market 2014-2022 ($ Million)
29. Australia Cardiac Biomarkers Market 2014-2022 ($ Million)
30. Roapac Cardiac Biomarkers Market 2014-2022 ($ Million)
31. Rest of the World Cardiac Biomarkers Market 2014-2022 ($ Million)
32. Latin America Cardiac Biomarkers Market 2014-2022 ($ Million)
33. Mena Cardiac Biomarkers Market 2014-2022 ($ Million)
34. Africa Cardiac Biomarkers Market 2014-2022 ($ Million)
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
- Abbott Diagnostics
- Alere Inc.
- Beckman Coulter
- Becton, Dickinson And Co.
- Bg Medicine Inc.
- Biomerieux
- Ekf Diagnostics Holdings, Inc.
- Merck & Co, Inc.
- Radiometer Medical
- Randox Laboratory
- Response Biomedical
- Roche Holding Ag
- Siemens Healthcare
- Singulex
- Thermo Fisher Scientific
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll